| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME FMO1 |
[1] |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| NCX-4040 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01394
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Environmental Pollutant |
| DME Modulation |
NCX-4040 induces the drug-metabolizing activity of DME FMO1 |
[2] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Amphibole asbestos |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00995
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Mixture |
| DME Modulation |
Amphibole asbestos inhibits the drug-metabolizing activity of DME FMO1 |
[3] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME FMO1 |
[4] |
| Cytarabine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00097
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cytarabine inhibits the expression of DME FMO1 |
[5] |
| Hydrogen peroxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00388
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydrogen peroxide inhibits the expression of DME FMO1 |
[6] |
| Pyrithione zinc |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00399
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Pyrithione zinc up-regulates the expression of DME FMO1 |
[7] |
| Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Valproic acid inhibits the expression of DME FMO1 |
[8] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Triclosan |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00560
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Triclosan up-regulates the expression of DME FMO1 |
[9] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Bisphenol A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Bisphenol A up-regulates the expression of DME FMO1 |
[10] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Beta-naphthoflavone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01220
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Beta-naphthoflavone inhibits the expression of DME FMO1 |
[11] |
|
|
|
|
|
|